Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children

Mise à jour : Il y a 4 ans
Référence : NCT01195779

Femme et Homme

  • | Pays :
  • Spain
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this observer-blind study is to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals' influenza vaccine GSK2584786A in healthy children 6 to 35 months of age.


Critère d'inclusion

  • Influenza

Liens